vs

Side-by-side financial comparison of CMB.TECH NV (CMBT) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $592.8M, roughly 1.2× CMB.TECH NV). Healthpeak Properties runs the higher net margin — 73.2% vs 32.3%, a 40.9% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -34.6%).

CMB.TECH, before October 2024 known as Euronav, is a crude oil tanker transport company, which consists of VLCCs, Suezmaxes and FSOs.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

CMBT vs DOC — Head-to-Head

Bigger by revenue
DOC
DOC
1.2× larger
DOC
$719.4M
$592.8M
CMBT
Growing faster (revenue YoY)
DOC
DOC
+37.6% gap
DOC
3.1%
-34.6%
CMBT
Higher net margin
DOC
DOC
40.9% more per $
DOC
73.2%
32.3%
CMBT

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CMBT
CMBT
DOC
DOC
Revenue
$592.8M
$719.4M
Net Profit
$191.2M
$114.0M
Gross Margin
Operating Margin
46.4%
17.4%
Net Margin
32.3%
73.2%
Revenue YoY
-34.6%
3.1%
Net Profit YoY
-63.3%
2406.4%
EPS (diluted)
$1.01
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBT
CMBT
DOC
DOC
Q4 25
$719.4M
Q3 25
$705.9M
Q2 25
$694.3M
Q1 25
$702.9M
Q4 24
$592.8M
$698.0M
Q3 24
$700.4M
Q2 24
$695.5M
Q1 24
$606.6M
Net Profit
CMBT
CMBT
DOC
DOC
Q4 25
$114.0M
Q3 25
$-117.1M
Q2 25
$31.7M
Q1 25
$42.8M
Q4 24
$191.2M
$4.5M
Q3 24
$85.9M
Q2 24
$146.0M
Q1 24
$6.7M
Gross Margin
CMBT
CMBT
DOC
DOC
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Q1 24
59.8%
Operating Margin
CMBT
CMBT
DOC
DOC
Q4 25
17.4%
Q3 25
9.2%
Q2 25
5.7%
Q1 25
7.7%
Q4 24
46.4%
-2.2%
Q3 24
14.1%
Q2 24
22.3%
Q1 24
3.7%
Net Margin
CMBT
CMBT
DOC
DOC
Q4 25
73.2%
Q3 25
-16.6%
Q2 25
4.6%
Q1 25
6.1%
Q4 24
32.3%
0.7%
Q3 24
12.3%
Q2 24
21.0%
Q1 24
1.1%
EPS (diluted)
CMBT
CMBT
DOC
DOC
Q4 25
$0.16
Q3 25
$-0.17
Q2 25
$0.05
Q1 25
$0.06
Q4 24
$1.01
$0.02
Q3 24
$0.12
Q2 24
$0.21
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBT
CMBT
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$38.9M
$467.5M
Total DebtLower is stronger
$2.6B
$9.8B
Stockholders' EquityBook value
$1.2B
$7.5B
Total Assets
$3.9B
$20.3B
Debt / EquityLower = less leverage
2.20×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBT
CMBT
DOC
DOC
Q4 25
$467.5M
Q3 25
$91.0M
Q2 25
$89.4M
Q1 25
$70.6M
Q4 24
$38.9M
$119.8M
Q3 24
$180.4M
Q2 24
$106.9M
Q1 24
$101.8M
Total Debt
CMBT
CMBT
DOC
DOC
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$2.6B
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Q1 24
$8.8B
Stockholders' Equity
CMBT
CMBT
DOC
DOC
Q4 25
$7.5B
Q3 25
$7.6B
Q2 25
$7.9B
Q1 25
$8.2B
Q4 24
$1.2B
$8.4B
Q3 24
$8.6B
Q2 24
$8.8B
Q1 24
$8.9B
Total Assets
CMBT
CMBT
DOC
DOC
Q4 25
$20.3B
Q3 25
$19.6B
Q2 25
$19.8B
Q1 25
$19.8B
Q4 24
$3.9B
$19.9B
Q3 24
$20.0B
Q2 24
$20.2B
Q1 24
$20.5B
Debt / Equity
CMBT
CMBT
DOC
DOC
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
2.20×
1.04×
Q3 24
1.00×
Q2 24
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBT
CMBT
DOC
DOC
Operating Cash FlowLast quarter
$204.4M
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
1.07×
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBT
CMBT
DOC
DOC
Q4 25
$1.3B
Q3 25
$315.0M
Q2 25
$363.5M
Q1 25
$279.4M
Q4 24
$204.4M
$1.1B
Q3 24
$318.2M
Q2 24
$316.2M
Q1 24
$152.6M
Free Cash Flow
CMBT
CMBT
DOC
DOC
Q4 25
$357.0M
Q3 25
Q2 25
Q1 25
Q4 24
$333.7M
Q3 24
Q2 24
Q1 24
FCF Margin
CMBT
CMBT
DOC
DOC
Q4 25
49.6%
Q3 25
Q2 25
Q1 25
Q4 24
47.8%
Q3 24
Q2 24
Q1 24
Capex Intensity
CMBT
CMBT
DOC
DOC
Q4 25
124.4%
Q3 25
Q2 25
Q1 25
Q4 24
105.6%
Q3 24
Q2 24
Q1 24
Cash Conversion
CMBT
CMBT
DOC
DOC
Q4 25
10.99×
Q3 25
Q2 25
11.48×
Q1 25
6.52×
Q4 24
1.07×
235.43×
Q3 24
3.71×
Q2 24
2.17×
Q1 24
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons